CEROW
CERO THERAPEUTICS WTS 29stockOTCWarrant
EODNov 13, 2026
0.00195USD+11.429%(+0.0002)5,000
CEROW Financials
In Q3 FY 2026 (ended ), CERO THERAPEUTICS WTS 29 (CEROW) reported net income of $4.02M, operating cash flow of −$3.03M, and assets of $1.83M (filed ).
Loading financial statements…